Indication
Acromegaly
Acromegaly is a rare, chronic endocrine disorder characterized by the autonomous hypersecretion of growth hormone (GH) following epiphyseal plate closure in adulthood, driven in most cases by a benign anterior pituitary adenoma. Read more about Acromegaly
48 drugs 41 manufacturers
Drugs that treat it
Common Acromegaly therapies.
SIGNIFOR LAR (pasireotide pamoate)
OCTREOTIDE ACETATE
BROMOCRIPTINE MESYLATE
BROMOCRIPTINE MESYLATE
BROMOCRIPTINE MESYLATE
SOMAVERT (pegvisomant)
OCTREOTIDE ACETATE
OCTREOTIDE ACETATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAcromegaly is a rare, chronic endocrine disorder characterized by the autonomous hypersecretion of growth hormone (GH) following epiphyseal plate closure in adulthood, driven in most cases by a benign anterior pituitary adenoma.
Excess circulating GH stimulates the liver and peripheral tissues to overproduce insulin-like growth factor 1 (IGF-1), resulting in progressive somatic and soft-tissue overgrowth.
Patients classically develop coarse facial features, prognathism, macroglossia, and enlargement of the hands and feet.
If unaddressed, sustained hormone elevation contributes to multi-organ system complications, prominently including hypertension, cardiomyopathy, obstructive sleep apnea, type 2 diabetes mellitus, and osteoarthritis.
- nih.gov
Acromegaly is a rare, chronic endocrine disorder characterized by the autonomous hypersecretion of growth hormone (GH) following epiphyseal plate closure in adulthood, driven in most cases by a benign anterior pituitary adenoma Excess circulating GH stimulates the liver and peripheral tissues to overproduce insulin-like growth factor 1 (IGF-1), resulting in progressive somatic and soft-tissue overgrowth Patients classically develop coarse facial features, prognathism, macroglossia, and enlargeme...
- endocrine.org
Acromegaly is a rare, chronic endocrine disorder characterized by the autonomous hypersecretion of growth hormone (GH) following epiphyseal plate closure in adulthood, driven in most cases by a benign anterior pituitary adenoma Excess circulating GH stimulates the liver and peripheral tissues to overproduce insulin-like growth factor 1 (IGF-1), resulting in progressive somatic and soft-tissue overgrowth
- guidelinecentral.com
Acromegaly is a rare, chronic endocrine disorder characterized by the autonomous hypersecretion of growth hormone (GH) following epiphyseal plate closure in adulthood, driven in most cases by a benign anterior pituitary adenoma Excess circulating GH stimulates the liver and peripheral tissues to overproduce insulin-like growth factor 1 (IGF-1), resulting in progressive somatic and soft-tissue overgrowth If unaddressed, sustained hormone elevation contributes to multi-organ system complications, ...
- nih.gov
Excess circulating GH stimulates the liver and peripheral tissues to overproduce insulin-like growth factor 1 (IGF-1), resulting in progressive somatic and soft-tissue overgrowth If unaddressed, sustained hormone elevation contributes to multi-organ system complications, prominently including hypertension, cardiomyopathy, obstructive sleep apnea, type 2 diabetes mellitus, and osteoarthritis
- karger.com
Patients classically develop coarse facial features, prognathism, macroglossia, and enlargement of the hands and feet
- mayoclinic.org
If unaddressed, sustained hormone elevation contributes to multi-organ system complications, prominently including hypertension, cardiomyopathy, obstructive sleep apnea, type 2 diabetes mellitus, and osteoarthritis
Personalize your experience
Follow Acromegaly and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.